REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 26th, 2022 • MediWound Ltd. • Medicinal chemicals & botanical products
This Registration Rights Agreement (this “Agreement”) is made and entered into as of [___], 2022, by and between MediWound Ltd., a company organized under the laws of the State of Israel (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 26th, 2022 • MediWound Ltd. • Medicinal chemicals & botanical products • New York
This securities purchase agreement (this “Agreement”) is dated as of September 22, 2022, between MediWound Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages attached hereto (each, including its successors and assignees, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT MEDIWOUND LTD.Placement Agent Ordinary Share Agreement • September 26th, 2022 • MediWound Ltd. • Medicinal chemicals & botanical products
THIS PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Authorized Share Increase Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the earlier of (i) four (4) year anniversary of the Initial Exercise Date and (ii) September 22, 2027 (the “Termination Date”), but not thereafter, to subscribe for and purchase from MEDIWOUND LTD., an Israeli company (the “Company”), up to ______ Ordinary Shares, NIS 0.01 par value (the “Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”) of the Company. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain engagement letter, dated as of August
PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT MEDIWOUND LTD.Pre-Funded Ordinary Share Agreement • September 26th, 2022 • MediWound Ltd. • Medicinal chemicals & botanical products
THIS PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Authorized Share Increase Date (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”), but not thereafter, to subscribe for and purchase from MEDIWOUND LTD., an Israeli company (the “Company”), up to ______ Ordinary Shares, NIS 0.01 par value (the “Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”) of the Company. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES A ORDINARY SHARE PURCHASE WARRANT MEDIWOUND LTD.Series a Ordinary Share Purchase Agreement • September 26th, 2022 • MediWound Ltd. • Medicinal chemicals & botanical products
THIS SERIES A ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Authorized Share Increase Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the four (4) year anniversary of the Initial Exercise Date (the “Termination Date”), but not thereafter, to subscribe for and purchase from MEDIWOUND LTD., an Israeli company (the “Company”), up to ______ Ordinary Shares, NIS 0.01 par value (the “Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”) of the Company. The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
